Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Product News
Thermo Fisher Unveils LC-MS Software
Sunday, July 14, 2013
Thermo Fisher's Mass Spectrometry group has updated its software packages to help customers harness the power of its LC-MS instruments.

Plexpress Launches Dedicated Canine ADME-Tox Service
Friday, July 05, 2013
TRACPACK DOG INDUCTION for preclinical drug candidate screening.

New Automated Immunosuppressive Drug Assays from Roche
Tuesday, June 25, 2013
Roche enables immunosuppressive drug assays to be consolidated onto main laboratory automated platforms.

Phenom-World Unveils the Third Generation Phenom Desktop SEM
Tuesday, June 25, 2013
With a magnification range up to 100,000x and resolution of 17nm the Phenom ProX delivers more detailed information than ever before.

Agilent Launches RapidFire 365 High-Throughput Mass Spectrometry System
Tuesday, June 11, 2013
Product provides walkaway mass spectrometric analysis for researchers working on drug discovery, clinical research and forensic toxicology.

Thermo Scientific Unveils LC-MS Software to Transform High Performance Mass Spectrometry
Tuesday, June 11, 2013
Company introduces 10 new or updated software packages at ASMS.

Optibrium Introduces StarDrop 5.4 to Target Novel, Safe and Efficacious Drugs
Tuesday, June 11, 2013
Next generation software adds modules for knowledge-based prediction of toxicity and application of over 20,000 bioisosteric transformations.

HUBER high precision thermoregulation in laboratories: ECO² - Economical and Ecological!
Friday, May 17, 2013
HUBER Petite Fleur®, Ministat® and Minichiller® are environmentally friendly and cost-effective thermoregulation machines charged with natural refrigerants, perfectly suited for laboratories: Eco friendly, small dimensions and low investment costs.

Molecular Devices to Exhibit at French Neuroscience 2013
Monday, May 13, 2013
Molecular Devices will be showcasing their Axon™ Digidata® 1550 Low-Noise Data Acquisition System.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 668
Scientific News
Label-Free Binding Analysis Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Vitamin E Keeps Muscles Healthy
Body builders have it right: vitamin E does help build strong muscles, and scientists appear to have figured out one important way it does it.
Microchip Captures Clusters of Circulating Tumor Cells
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads.
New Method For Measuring The Concentration Of Medicines In The Blood
Researchers at EPFL have come up with a quick and portable new device for measuring the amount of medicinal drugs in blood.
Alternate Administration Routes for Psychotropic Drugs Reviewed
A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.
Epilepsy Drug Metabolism Test Launched for Epilepsy and Seizure Disorders
Courtagen Life Sciences, Inc have announced the release of a NGS test focused on detection of anti-epileptic drug (AED) compatibilities and interactions for patients receiving treatment for epilepsy or other seizure disorders.
Supercooling May Aid Drug Delivery
A new study published is the first to break down the rules governing the complex process of crystallization through rapid-cooling.
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Neuropsychiatric Drug Candidate Shows Good Safety & Tolerability
Transition Therapeutics announces results from Phase 1 AME & renal clearance clinical studies of neuropsychiatric drug candidate ELND005.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters